These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30801741)

  • 41. Pharmacokinetics of florfenicol and its metabolite florfenicol amine in crucian carp (Carassius auratus) at three temperatures after one single intramuscular injection.
    Yang F; Yang F; Kong T; Wang G; Bai D; Liu B
    J Vet Pharmacol Ther; 2018 Oct; 41(5):739-745. PubMed ID: 29892973
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics/pharmacodynamics cut-off determination for fosfomycin using Monte Carlo simulation in healthy horses.
    Kuroda T; Minamijima Y; Niwa H; Mita H; Tamura N; Fukuda K; Toutain PL; Ohta M
    J Vet Med Sci; 2024 Apr; 86(4):413-420. PubMed ID: 38346727
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical efficacy of florfenicol administered in the drinking water against Ornithobacterium rhinotracheale in turkeys housed in different environmental conditions: a pharmacokinetic/pharmacodynamic approach.
    Watteyn A; Russo E; Garmyn A; De Baere S; Pasmans F; Martel A; Haesebrouck F; Montesissa C; De Backer P; Croubels S
    Avian Pathol; 2013; 42(5):474-81. PubMed ID: 23930788
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics of florfenicol after intravenous administration in Escherichia coli lipopolysaccharide-induced endotoxaemic sheep.
    Pérez R; Palma C; Drápela C; Sepulveda M; Espinoza A; Peñailillo AK
    J Vet Pharmacol Ther; 2015 Apr; 38(2):144-9. PubMed ID: 25229993
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epidemiological and PK/PD cutoff values determination and PK/PD-based dose assessment of gamithromycin against Haemophilus parasuis in piglets.
    Zhou YF; Bu MX; Liu P; Sun J; Liu YH; Liao XP
    BMC Vet Res; 2020 Mar; 16(1):81. PubMed ID: 32138735
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Integration of pharmacokinetic and pharmacodynamic indices of marbofloxacin in turkeys.
    Haritova AM; Rusenova NV; Parvanov PR; Lashev LD; Fink-Gremmels J
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3779-85. PubMed ID: 16940071
    [TBL] [Abstract][Full Text] [Related]  

  • 47.
    Zhou YF; Tao MT; He YZ; Sun J; Liu YH; Liao XP
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038275
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of enrofloxacin, florfenicol and amoxicillin against Ornithobacterium rhinotracheale and Escherichia coli O2:K1 dual infection in turkeys following APV priming.
    Marien M; Decostere A; Duchateau L; Chiers K; Froyman R; Nauwynck H
    Vet Microbiol; 2007 Mar; 121(1-2):94-104. PubMed ID: 17187945
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative pharmacokinetics of florfenicol in healthy and Pasteurella multocida-infected Gaoyou ducks.
    Lan W; Xiao X; Jiang Y; Jiang L; Zhao X; Yu Z; Zhu B; Li C; Bian L; Wang Z
    J Vet Pharmacol Ther; 2019 May; 42(3):355-360. PubMed ID: 30912167
    [TBL] [Abstract][Full Text] [Related]  

  • 50. F14:A-:B- and IncX4 Inc group cfr-positive plasmids circulating in Escherichia coli of animal origin in Northeast China.
    Wang X; Zhu Y; Hua X; Chen F; Wang C; Zhang Y; Liu S; Zhang W
    Vet Microbiol; 2018 Apr; 217():53-57. PubMed ID: 29615256
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antimicrobial resistance in Escherichia coli strains isolated from Swiss weaned pigs and sows.
    Stannarius C; Bürgi E; Regula G; Zychowska MA; Zweifel C; Stephan R
    Schweiz Arch Tierheilkd; 2009 Mar; 151(3):119-25. PubMed ID: 19263381
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Florfenicol concentrations in ovine tear fluid following intramuscular and subcutaneous administration and comparison with the minimum inhibitory concentrations against mycoplasmal strains potentially involved in infectious keratoconjunctivitis.
    Regnier A; Laroute V; Gautier-Bouchardon A; Gayrard V; Picard-Hagen N; Toutain PL
    Am J Vet Res; 2013 Feb; 74(2):268-74. PubMed ID: 23363353
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vivo pharmacokinetic/Pharmacodynamic modeling of Enrofloxacin against Escherichia coli in broiler chickens.
    Xiao X; Jiang L; Lan W; Jiang Y; Wang Z
    BMC Vet Res; 2018 Nov; 14(1):374. PubMed ID: 30497453
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The acute phase response induced by Escherichia coli lipopolysaccharide modifies the pharmacokinetics and metabolism of florfenicol in rabbits.
    Pérez R; Palma C; Burgos R; Jeldres JA; Espinoza A; Peñailillo AK
    J Vet Pharmacol Ther; 2016 Apr; 39(2):183-90. PubMed ID: 26010096
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetic-pharmacodynamic modelling of danofloxacin in turkeys.
    Haritova AM; Rusenova NV; Parvanov PR; Lashev LD; Fink-Gremmels J
    Vet Res Commun; 2006 Oct; 30(7):775-89. PubMed ID: 17004040
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetic-pharmacodynamic modelling for the determination of optimal dosing regimen of florfenicol in Nile tilapia (Oreochromis niloticus) at different water temperatures and antimicrobial susceptibility levels.
    Rairat T; Hsieh CY; Thongpiam W; Chou CC
    J Fish Dis; 2019 Aug; 42(8):1181-1190. PubMed ID: 31157416
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ex vivo antibacterial activity of levofloxacin against Escherichia coli and its pharmacokinetic profile following intravenous and oral administrations in broilers.
    Lee HK; DeVito V; Vercelli C; Tramuta C; Nebbia P; Re G; Kovalenko K; Giorgi M
    Res Vet Sci; 2017 Jun; 112():26-33. PubMed ID: 28113087
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activity of florfenicol for Actinobacillus pleuropneumoniae and Pasteurella multocida using standardised versus non-standardised methodology.
    Dorey L; Hobson S; Lees P
    Vet J; 2016 Dec; 218():65-70. PubMed ID: 27938711
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of the antimicrobial activity of florfenicol against bacteria isolated from bovine and porcine respiratory disease.
    Shin SJ; Kang SG; Nabin R; Kang ML; Yoo HS
    Vet Microbiol; 2005 Mar; 106(1-2):73-7. PubMed ID: 15737475
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro and ex vivo antibacterial activity of levofloxacin against Pasteurella multocida and Escherichia coli isolated from rabbits (Oryctolagus cuniculus) - A preliminary study.
    Sitovs A; Skadins I; Purvina S; Bandere D
    J Vet Pharmacol Ther; 2023 Sep; 46(5):332-343. PubMed ID: 37060264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.